Overview
Healthcann is focused on advancing cannabinoids by developing drug delivery systems that enhance the effectiveness and accessibility of cannabinoid-based treatments. The company aims to create state-of-the-art formulations that provide precise dosing and fast, long-lasting relief for various health conditions. Their technology, including AdvanDrop®, addresses challenges associated with oral delivery of cannabinoids to improve patient compliance and outcomes.
Financials
Revenue history (in k)
Filing timeliness
3 of 4 financial statements were filed late (the longest delay 268 days for 2023). 2 of 4 audited by a statutory auditor.
- 202523/04/2026
- 202403/09/2025
- 202309/04/2025
- 202211/08/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the following are authorised to make declarations of will on behalf of the company: the President of the Management Board acting independently, the Vice-President of the Management Board acting independently, or a member of the management board acting jointly with the President of the Management Board or the Vice-President of the Management Board.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-06-10.
No bank accounts reported to the VAT Taxpayer Register.
Debt
2 active proceedings recorded in KRZ.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Nov 14, 2024 | Bankruptcy proceedings for an entrepreneur | In progress | |
| Jul 26, 2024 | Petition to declare entrepreneur bankruptcy | Closed |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jul 14, 2023 | Shareholders' meeting convened | |
| Nov 23, 2022 | Commercial Companies Code notice | |
| Oct 13, 2022 | Commercial Companies Code notice |
Public aid
20 public aid cases recorded, with a total value of $1,106,733.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 15, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $1,204$1,204 | Wrocławski Park Technologiczny S.A. | |
| Jun 16, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $1,236$1,236 | Wrocławski Park Technologiczny S.A. | |
| Apr 3, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $31,600$31,600 | Polska Agencja Inwestycji I Handlu S.A. |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-12-01 | Development of innovative formulations of orally administered biologically active compounds with increased bioavailability | $834.7K$834,712 | Operational Programme Smart Growth |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| BiottsS.A. | $372,115.60 | biotts.com | ||
| Green ZebrasS.A. | $328,658.91 | whygreenzebras.pl | ||
| BiocamS.A. | $327,799.68 | biocam.ai | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| TCIsp. z o.o. | $218,471.87 | tci.pl | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| Pharmaxi Polandsp. z o.o. | $152,292.34 | pharmaxi.com.ua | ||
| Receptonsp. z o.o. | $50,611.05 | receptonbiotech.com | ||
| Zawamedsp. z o.o. | $43,909.06 | zawamed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-01-09 | Name change (Healthcann → Healthcann Spółka Akcyjna W Upadłości) | |
| 2023-08-30 | Share capital increase (200,014.40 PLN → 207,963.50 PLN) | |
| 2022-08-04 | Entered in the register |
FAQ
Last updated: 2026-04-23